87447-47-0Diltiazem EP Impurity B

Diltiazem EP Impurity B, also referred to in pharmacopoeias as Diltiazem Related Compound B, is a meticulously characterized reference standard. It adheres to stringent regulatory guidelines, including those established by USP, EMA, JP, and BP. This product plays a vital role in Abbreviated New Drug Applications (ANDA), New Drug Applications (NDA), and the commercial manufacturing of Diltiazem. Furthermore, it is accompanied by a comprehensive Structure Elucidation Report (SER), ensuring its accuracy and reliability across various analytical applications. Diltiazem Related Compound B (CAS No.: 87447-47-0) or (2S,3S)-3-(Acetyloxy)-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one is a potent metabolite of Diltiazem which is an orally and intravenously potent calcium channel blocking compound and is known to be effective and has tolerance in the body. It is evaluated for the treatment of stable angina and angina due to coronary artery spasms.